etoposide has been researched along with Medulloblastoma in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 32 (28.07) | 18.2507 |
2000's | 44 (38.60) | 29.6817 |
2010's | 33 (28.95) | 24.3611 |
2020's | 5 (4.39) | 2.80 |
Authors | Studies |
---|---|
Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T | 1 |
Hara, J; Okada, K; Sakamoto, H; Soejima, T; Yamasaki, K | 1 |
Erdreich-Epstein, A; Mahdi, MY; Pathania, AS; Ren, X; Shackleford, GM | 1 |
Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM | 1 |
Hara, J; Hirato, J; Okada, K; Sakamoto, H; Soejima, T | 1 |
Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A | 1 |
Erdreich-Epstein, A; Fernandez, GE; Moats, RA; Pathania, AS; Ren, X; Shackleford, GM; Tran, A; Xu, J; Zhang, Y | 1 |
Abedalthagafi, M; Al-Harbi, M; Mobark, NA; Mosleh, O; Santagata, S; Snuderl, M | 1 |
Anurathapan, U; Dhanachai, M; Hansasuta, A; Hongeng, S; Jinawath, A; Khongkhatithum, C; Mahachoklertwattana, P; Pakakasama, S; Sirachainan, N | 1 |
Andión, M; Lassaletta, A; Lavarino, C; López-Pino, MA; Madero, L; Perez-Somarriba, M | 1 |
Cowman, S; Fan, YN; Pizer, B; Sée, V | 1 |
Fillmore, HL; Loveson, KF; Mather, RL | 1 |
Abujamra, AL; Brunetto, AL; de Farias, CB; Lenz, G; Nör, C; Roesler, R; Sassi, FA; Schwartsmann, G | 1 |
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
Clement, J; Drabick, JJ; Frauenhoffer, E; Rybka, W; Varlotto, J | 1 |
Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY | 1 |
Barnes, P; Burger, P; Chen, Z; Friedman, H; Kun, L; Polkinghorn, WR; Tarbell, NJ; Yock, T; Zhou, T | 1 |
Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I | 1 |
Booth, L; Conley, A; Cruickshanks, N; Dent, P; Grant, S; Kukreja, RC; Malkin, M; Poklepovic, A; Roberts, JL | 1 |
Fan, YN; Meley, D; Pizer, B; Sée, V | 1 |
Alexander, C; Ashford, MB; Garnett, MC; Gellert, PR; Ivanov, DP; Parker, TL; Walker, DA | 1 |
Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
Bourneau-Martin, D; Drablier, G; Lagarce, L; Lainé-Cessac, P; Le Louet, H; Leguay, Z; Pellier, I | 1 |
Abrari, A; Gupta, A; Kumar, A; Patir, R; Vaishya, S | 1 |
Craveiro, RB; Dilloo, D; Ehrhardt, M; Goetz, B; Olschewski, M; Pietsch, T; Velz, J | 1 |
Aoyama, H; Fujieda, K; Ikeda, J; Ishii, N; Iwasaki, Y; Kashiwamura, M; Sawamura, Y; Shirato, H; Taguchi, H; Yasuda, K | 1 |
Chen, SH; Jaing, TH; Lin, KL; Liu, LY; Lui, TN; Tseng, CK | 1 |
Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M | 1 |
Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G | 1 |
Asphahani, F; Buckmaster, R; Thein, M; Xu, J; Zhang, M | 1 |
Broaddus, WC; Fillmore, HL; Kadian, R; Kumar, A; Tye, GW; Van Meter, TE | 1 |
Béliveau, R; Berger-Thibault, N; Boivin, D; Gingras, D; Labbé, D; Provençal, M; Rivard, GE; Veitch, R | 1 |
Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Shi, W | 1 |
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A | 1 |
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
McDowell, H; Meley, D; Pizer, B; Sée, V; Spiller, DG; White, MR | 1 |
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M; Yamashita, Y | 1 |
Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
Bhat, K; Doucette, M; Gu, Y; Hsieh, TC; Kang, JX; Law, B; Liu, X; Qian, SY; Wang, F; Wong, ET; Wu, E; Zhou, S | 1 |
Botturi, A; Dimeco, F; Erbetta, A; Fariselli, L; Ferroli, P; Franzini, A; Gaviani, P; Lamperti, E; Milanesi, I; Pollo, B; Salmaggi, A; Silvani, A | 1 |
Clifford, SC; Coyle, B; Grundy, R; Levesley, J; Lindsey, JC; Lusher, ME | 1 |
Kivivuori, SM; Nygaard, R | 1 |
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C | 1 |
Joung, YS; Kim, JH; Koo, HH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Suh, YL; Sung, KW; Yoo, KH | 1 |
Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK | 1 |
Chaudhry, A; Forsyth, P; Russell, J; Stewart, DA; Zia, MI | 1 |
Baeksgaard, L; Sørensen, JB | 1 |
Bailey, CC; Ellison, D; Gilbertson, R; Imeson, J; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, K; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R | 1 |
McLean, TW | 1 |
Bailey, CC; Ellison, D; Gilbertson, R; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, KJ; Saran, F; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
Chi, SN; Finlay, JL; Gardner, SL; Knopp, EA; Levy, AS; Miller, DC; Weiner, HL; Wisoff, JH | 1 |
Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
Cohen, ZR; Fuller, GN; Lang, FF; Majumder, S; Price, RE; Sawaya, R; Su, X | 1 |
Mori, H; Nishiyama, K; Takahashi, H; Tanaka, R; Umezu, H; Yoshimura, J | 1 |
Alcutt, D; Grogan, L; Morris, P; Nasser, Q; Razak, AR | 1 |
Chaku, J; Kellie, SJ; Lockwood, LR; O'Regan, P; Waters, KD; Wong, CK | 1 |
Babin, A; Bours, D; Carrie, C; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Neuenschwander, S; Oyharcabal-Bourden, V; Pagnier, A; Pichon, F; Ruchoux, M; Sariban, E; Vinchon, M | 1 |
Takahashi, H; Tanaka, R | 1 |
Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A | 1 |
Barnes, P; Chen, Z; Fitzgerald, TJ; Friedman, HS; Glicksman, A; Kepner, JL; Kessel, S; Kun, L; Laurie, F; Miralbell, R; Tarbell, NJ; Urie, M; Zhou, T | 1 |
Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S | 1 |
Bader, P; Beck, JF; Hartwig, C; Heesch, S; Kumar, KS; Maass, M; Müller, C; Sonnemann, J | 1 |
Alapetite, C; Bertozzi, AI; Bours, D; Bracard, S; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Pagnier, A; Pichon, F; Rialland, X; Sariban, E; Tubiana, AL; Verlooy, J; Zerah, M | 1 |
Ahn, SD; Cho, EJ; Choi, ES; Ghim, TT; Koo, HH; Lim, DH; Ra, YS; Shin, HJ; Sung, KW; Yoo, KH | 1 |
Hongo, T; Nishizawa, S; Ohzeki, T; Okada, S; Sakaguchi, K; Suzuki, K | 1 |
Iwaki, T; Kuga, D; Matsumoto, K; Miyamoto, K; Mizoguchi, M; Niiro, H; Ohta, M; Sasaki, T; Shono, T; Suzuki, SO; Uesaka, T | 1 |
Betanzos-Cabrera, Y; Cerecedo-Díaz, F; del Angel, VW; Diegopérez-Ramírez, J; López-Aguilar, E; Rivera-Márquez, H; Sepúlveda-Vildósola, AC; Siordia-Reyes, G | 1 |
Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR | 1 |
Sterling-Levis, K; White, L | 1 |
Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T | 1 |
Abd-El-Aal, HH | 1 |
Hotta, T; Kawamoto, K; Kiya, K; Kurisu, K; Mikami, T; Uozumi, T | 1 |
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW | 1 |
Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y | 1 |
Bouffet, E; Chastagner, P; Doz, F; Gentet, JC; Kalifa, C; Mazingue, F; Plantaz, D; Roché, H; Sariban, E; Tron, P | 1 |
Boor, R; Gutjahr, P; Huber, A | 1 |
Craver, RD; Gohd, RS; Hierholzer, JC; Sundin, DR | 1 |
Chang, TK; Hsien, YL; Hwang, B; Jeng, MJ; Tang, RB; Wong, TT | 1 |
Lasorella, A; Mastrangelo, R; Riccardi, R; Tornesello, A | 1 |
Ashley, DM; Duffner, PK; Friedman, HS; Gajjar, A; Kerby, T; Kun, L; Longee, D; Meier, L; Smith, S; Zalduondo, FM | 1 |
Kowada, M; Mineura, K; Sasajima, T; Takeda, O; Watanabe, A | 1 |
Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
Asai, Y; Matsushita, K; Naitoh, T; Suetsugu, S | 1 |
Borsi, J; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
Leo, E; Lindemann, A; Schlegel, PG | 1 |
Chamberlain, MC; Kormanik, PA | 1 |
Allen, JC; Bostrom, BC; Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Li, H; Rosenblum, M; Sender, LS; Yates, A | 1 |
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
Alla, P; Carloz, E; de Jauréguiberry, JP; Gisserot, O; Jaubert, D; Valance, J | 1 |
de Tribolet, N; Dietrich, PY; Pizzolato, G; Zona, G | 1 |
Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
Arias-Gomez, J; Cerecedo-Diaz, F; Lopez-Aguilar, E; Quintana-Roldan, G; Rivera-Marquez, H; Santacruz-Castillo, E; Sepulveda-Vildosola, AC; Valdez-Sanchez, M | 1 |
Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M | 1 |
Plummer, ER; Roberts, JT | 1 |
Carapella, C; Castello, MA; Maurizi, P; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
Bondiau, PY; Foa, C; Magné, N; Otto, J; Thyss, A | 1 |
Chamberlain, MC; Glantz, MJ; Greenberg, HS; Wang, S | 1 |
Mazeron, JJ; Noël, G | 1 |
Bode, U; Fleischhack, G; Hasan, C; Hettmer, S; Jaehde, U; Reif, S | 1 |
Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
Ashley, DM; Chow, CW; Gray, AZ; Hawkins, CJ; Riffkin, CD | 1 |
Dhodapkar, K; Dunkel, IJ; Finlay, J; Gardner, S; Sapp, M; Thoron, L | 1 |
Ash, RC; Beatty, PA; Lundberg, JH; Weissman, DE | 1 |
Kanai, H; Mabe, H; Nagai, H; Wakabayashi, S; Yamashita, N | 1 |
Hamano, S; Izawa, I; Kokunai, T; Kudo, H; Kuwamura, K; Matsumoto, S; Sawa, H; Tamaki, N; Tatsumi, S | 1 |
Lihou, MG; Smith, PJ; Tomlinson, FH | 1 |
Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD | 1 |
Douglass, EC; Etcubanas, EE; Fairclough, DL; Horowitz, ME; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JW; Mulhern, RK; Sanford, RA | 1 |
Castello, MA; Clerico, A; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P | 1 |
Gutjahr, P; Huber, A | 1 |
5 review(s) available for etoposide and Medulloblastoma
Article | Year |
---|---|
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosphamide; Emergency Medical Services; Etoposide; Humans; Life Style; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Neurosurgical Procedures; Radiotherapy; Self-Help Groups; Social Support; Spinal Puncture; Vincristine | 2003 |
[Chemotherapy for brain tumor].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine | 2005 |
Metastatic adult medulloblastoma showing prolonged response to chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors; Vincristine | 1999 |
Adult medulloblastoma: multiagent chemotherapy.
Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid Shunts; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Hematologic Diseases; Humans; Infratentorial Neoplasms; Life Tables; Lomustine; Male; Medulloblastoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine | 2001 |
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Remission Induction | 1990 |
28 trial(s) available for etoposide and Medulloblastoma
Article | Year |
---|---|
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat | 2022 |
Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Craniospinal Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Prognosis; Survival Rate; Vincristine | 2020 |
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Staging; Prognosis; Risk Factors; Vincristine; Young Adult | 2013 |
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis | 2008 |
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult | 2009 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Neoplasm Recurrence, Local; Quality of Life; Radiotherapy; Salvage Therapy; Thiotepa; Young Adult | 2010 |
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome | 2010 |
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Medulloblastoma; Middle Aged; Survival Analysis | 2012 |
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome | 2002 |
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; United Kingdom; Vincristine | 2003 |
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Medulloblastoma; Proportional Hazards Models; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Male; Medulloblastoma; Mesna; Methotrexate; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dementia, Vascular; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate | 2005 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cranial Irradiation; Etoposide; Humans; Infratentorial Neoplasms; Medulloblastoma; Quality Assurance, Health Care; Radiotherapy; Spinal Neoplasms; Survival Rate | 2006 |
High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Contraindications; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Sepsis; Supratentorial Neoplasms; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Salvage Therapy | 2007 |
Pre-irradiation chemotherapy in high risk medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis | 2006 |
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 1995 |
Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Treatment Outcome | 1994 |
[Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Nitrosourea Compounds | 1996 |
[In vivo effect of etoposide on the pharmacokinetics of methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Clinical Protocols; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Humans; Medulloblastoma; Methotrexate | 1996 |
Chronic oral VP-16 for recurrent medulloblastoma.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Time Factors | 1997 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine | 1998 |
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Pressure Liquid; Etoposide; Female; Half-Life; Humans; Injections, Intraventricular; Male; Medulloblastoma; Neoplasm Metastasis | 2001 |
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis | 1991 |
81 other study(ies) available for etoposide and Medulloblastoma
Article | Year |
---|---|
Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Medulloblastoma; Melphalan; Methotrexate; Prognosis; Prospective Studies; Registries; Survival Rate | 2020 |
GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cerebellar Neoplasms; Cisplatin; Etoposide; G-Protein-Coupled Receptor Kinase 2; HEK293 Cells; Humans; Medulloblastoma; Phosphorylation | 2019 |
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Etoposide; Female; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Retrospective Studies; Rhabdoid Tumor; Teratoma; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2020 |
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult | 2020 |
PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB.
Topics: Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cisplatin; Etoposide; Glioblastoma; HEK293 Cells; Humans; Medulloblastoma; NF-kappa B | 2017 |
A case of molecularly profiled extraneural medulloblastoma metastases in a child.
Topics: Chemotherapy, Adjuvant; Child, Preschool; Craniospinal Irradiation; Cyclophosphamide; Dose-Response Relationship, Radiation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Isotretinoin; Magnetic Resonance Imaging; Male; Medulloblastoma; N-Myc Proto-Oncogene Protein; Postoperative Period; Proto-Oncogene Proteins c-myc; Vincristine | 2018 |
Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Medulloblastoma; Vincristine | 2018 |
Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Etoposide; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local | 2019 |
Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Topics: Cell Cycle; Cell Cycle Proteins; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Radiation Tolerance | 2019 |
Human Sialic acid O-acetyl esterase (SIAE) - mediated changes in sensitivity to etoposide in a medulloblastoma cell line.
Topics: Acetylation; Acetylesterase; Acetyltransferases; Brain Neoplasms; Cell Line, Tumor; Child; Clone Cells; Etoposide; Gangliosides; Humans; Medulloblastoma; Membrane Potential, Mitochondrial | 2019 |
The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.
Topics: Biomarkers, Tumor; Brain Neoplasms; Butyric Acid; Cell Death; Cell Differentiation; Cell Survival; Etoposide; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; RNA, Messenger; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2013 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recurrence; Sarcoma, Ewing; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2013 |
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Retrospective Studies; Salvage Therapy; Vincristine; Young Adult | 2013 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome | 2013 |
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Medulloblastoma; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vincristine | 2014 |
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Genes, p53; Humans; Medulloblastoma; MicroRNAs; Mutation; Up-Regulation | 2014 |
In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; Neural Stem Cells; Spheroids, Cellular | 2015 |
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine | 2016 |
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
Topics: Acute Disease; Benzyl Alcohols; Carboplatin; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Medulloblastoma; Organophosphorus Compounds | 2016 |
Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Critical Care; Cyclophosphamide; Drug Administration Schedule; Etoposide; Histone Deacetylase Inhibitors; Humans; Infant; Longitudinal Studies; Male; Medulloblastoma; Neoadjuvant Therapy; Neurocognitive Disorders; Neurodevelopmental Disorders; Treatment Outcome; Valproic Acid; Vincristine | 2016 |
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Indazoles; Medulloblastoma; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides | 2017 |
Multivariate survival analysis of children with medulloblastoma--a single-center experience.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Multivariate Analysis; Radiation-Sensitizing Agents; Survival Analysis | 2008 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2009 |
Detection of drug-induced cellular changes using confocal Raman spectroscopy on patterned single-cell biosensors.
Topics: Antineoplastic Agents; Apoptosis; Biosensing Techniques; Cell Adhesion; Cell Line, Tumor; Cell Survival; Etoposide; Flow Cytometry; Gold; Humans; In Situ Nick-End Labeling; Medulloblastoma; Microarray Analysis; Spectrum Analysis, Raman; Time Factors | 2009 |
The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Child; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Humans; Isoenzymes; Medulloblastoma; Phosphorylcholine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Transfection | 2009 |
Tissue factor mediates the HGF/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Inhibitor of Apoptosis Proteins; Medulloblastoma; Microtubule-Associated Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-met; RNA, Small Interfering; Signal Transduction; Survivin; Thromboplastin; Time Factors; Transfection; Tumor Suppressor Protein p53 | 2010 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma.
Topics: Caspases; Cell Death; Cell Line, Tumor; Cerebellar Neoplasms; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; NF-kappa B; Phosphorylation; Receptors, Death Domain; Transcription Factor RelA; Tumor Suppressor Protein p53 | 2010 |
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Retrospective Studies; Treatment Outcome | 2011 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Repair; Docosahexaenoic Acids; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Inhibitor of Apoptosis Proteins; Medulloblastoma; Mitogen-Activated Protein Kinase 14; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin; Transcription Factors | 2011 |
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blotting, Western; Caspases; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Etoposide; Humans; Immunoenzyme Techniques; Medulloblastoma; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Suppressor Proteins | 2011 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome | 2012 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide | 2012 |
Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Medulloblastoma; Melphalan; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2002 |
Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cisplatin; Etoposide; Fluid Therapy; Humans; Liver Neoplasms; Male; Medulloblastoma; Renal Dialysis; Tumor Lysis Syndrome | 2003 |
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome | 2003 |
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.
Topics: Adenoviridae; Animals; Apoptosis; Brain; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Etoposide; Green Fluorescent Proteins; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Medulloblastoma; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neurons; Repressor Proteins; Stem Cells; Time Factors; Transcription Factors; Transcription, Genetic | 2005 |
[Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Etoposide; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Medulloblastoma; Nimustine; Remission Induction | 2005 |
Medulloblastoma in two successive pregnancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Medulloblastoma; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vincristine | 2005 |
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy Dosage; Spinal Canal; Survival Rate | 2005 |
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole | 2007 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Medulloblastoma; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiosurgery; Radiotherapy Dosage; Retrospective Studies | 2006 |
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Butyrates; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Medulloblastoma; Membrane Glycoproteins; Membrane Potentials; Mitochondrial Membranes; Radiation-Sensitizing Agents; Radiation, Ionizing; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine; Vorinostat | 2006 |
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Medulloblastoma; Postoperative Care; Prospective Studies; Risk Factors; Treatment Outcome | 2006 |
Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Gene Expression Profiling; Humans; Immunohistochemistry; Medulloblastoma; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |
Clinical and molecular parameters for risk stratification in Mexican children with medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Medulloblastoma; Mexico; Probability; Receptor, ErbB-2; Risk; Risk Assessment; Survival Rate; Time Factors | 2007 |
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Medulloblastoma; Mice; Mice, Nude; Neuroectodermal Tumors, Primitive; Time Factors; Vincristine; Xenograft Model Antitumor Assays | 2008 |
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2008 |
In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Drug Synergism; Etoposide; Female; Humans; Indicators and Reagents; Lymphotoxin-alpha; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1994 |
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma | 1995 |
Etoposide treatment in recurrent medulloblastoma.
Topics: Adult; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Frontal Lobe; Humans; Male; Medulloblastoma; Neoplasm Metastasis; Prognosis; Recurrence; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 1994 |
Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Infant; Macaca mulatta; Male; Medulloblastoma; Meningitis, Aseptic; Parainfluenza Virus 3, Human; Vincristine | 1993 |
Preirradiation chemotherapy for very young children with brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Ependymoma; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Male; Medulloblastoma; Neurologic Examination; Vinblastine | 1993 |
Carboplatin and cisplatin in medulloblastoma at diagnosis: "comparable efficacy?".
Topics: Antineoplastic Agents; Carboplatin; Child; Etoposide; Humans; Medulloblastoma; Treatment Outcome | 1996 |
Response of recurrent medulloblastoma to low-dose oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local | 1996 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms | 1996 |
[A patient with lung metastasis of medulloblastoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Male; Medulloblastoma; Spinal Cord Neoplasms | 1996 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous | 1998 |
[Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Meningitis; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oculomotor Nerve; Polyradiculopathy | 1998 |
Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Emergencies; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma | 1998 |
Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Humans; Infant; Medulloblastoma; Remission Induction | 1998 |
Pharmacokinetics of etoposide in plasma and cerebrospinal fluid in the space left by tumor removal.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma | 1999 |
Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Medulloblastoma | 1999 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2000 |
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Germany; Humans; Ifosfamide; Lomustine; Medulloblastoma; Mesna; Nervous System Diseases; Neutropenia; Postoperative Period; Prospective Studies; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 2001 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Topics: Adolescent; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Brain Neoplasms; Cell Survival; Child; Child, Preschool; Colorimetry; Culture Media, Conditioned; DNA, Complementary; Drug Resistance, Neoplasm; Etoposide; Fas Ligand Protein; fas Receptor; Female; Ganglioglioma; Germinoma; Glioblastoma; Humans; Infant; Jurkat Cells; Male; Medulloblastoma; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neuroblastoma; Neuroectodermal Tumors, Primitive; Pineal Gland; Pinealoma; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 2001 |
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medical Records; Medulloblastoma; Neoadjuvant Therapy; Neoplasm Staging; Neuroectodermal Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2002 |
Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Lymphatic Metastasis; Male; Medulloblastoma; Prevalence; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 1992 |
[A case of extraneural metastasis of medulloblastoma successfully treated with cisplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Male; Medulloblastoma; Remission Induction; Thoracic Neoplasms | 1992 |
Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neurologic Examination; Tomography, X-Ray Computed | 1992 |
Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas.
Topics: Alkylating Agents; Amsacrine; Cell Division; Cell Survival; Cross-Linking Reagents; Cytarabine; DNA Damage; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Hydroxyurea; In Vitro Techniques; Karyotyping; Medulloblastoma; Teniposide; Tumor Cells, Cultured; Vincristine | 1991 |
High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Glioblastoma; Hearing Loss, Sensorineural; Humans; Infant; Medulloblastoma; Remission Induction | 1990 |
Treatment of medulloblastoma.
Topics: Adolescent; Cerebellar Neoplasms; Etoposide; Humans; Male; Medulloblastoma; Remission Induction | 1990 |